Answers · Valuation & Worth
How do you value patents in M&A due diligence?
Updated June 2026
The short answer
In a deal, patents get examined in two passes: verification, which confirms the target owns what it claims free of landmines, and valuation, which establishes what the assets are worth to this specific buyer. Published estimates commonly put IP due diligence at two to six weeks, so both passes have to run inside the deal calendar rather than alongside it.
The valuation pass differs from a standalone appraisal in one fundamental way: value is computed to the acquirer. Overlap with the buyer's roadmap, exclusion value against the buyer's competitors, and integration plans all change the number, which is why the same portfolio can rationally be worth different amounts to different bidders.
The verification pass, and whose job it is
Verification is largely legal work: chain of title and recorded assignments, inventor agreements, encumbrances such as licenses already granted, security interests, standards commitments, government rights in funded inventions, and any validity or enforcement history. Deal counsel runs this, and ipCG is explicit about the boundary: we are a consultancy, not a law firm, and we do not render title or validity opinions.
What we run in parallel is the business-side examination the legal checklist does not cover: whether the patents actually protect the products generating the revenue being acquired, how the portfolio compares against the competitive set, and which claimed crown jewels are real.
How the valuation pass works
The core question is what the portfolio is worth in the buyer's hands. For an acquirer, much of that worth is the alternative it avoids: what it would otherwise have to pay to license the same freedom to operate, which is often the real economic reason to buy a portfolio rather than license it. We connect the patents to the products that generate the acquired revenue, to gauge how much of it they genuinely protect, then weigh what the same patents are worth to the buyer's own products and competitive position, where keeping a key rival out can be worth more to the buyer than the revenue the patents protect inside the target. Income methods, usually relief from royalty, carry most of the weight, with market comparables as a cross-check. Our ipValue Model has supported more than $2 billion in cumulative transaction value, much of it in exactly this setting.
Findings move price in both directions. Key families expiring inside the synergy window, exclusive licenses already granted in the buyer's core market, or patents that do not cover the flagship product all argue the price down. A portfolio that blocks the buyer's main rival argues it up, sometimes past what the target itself understood.
Who does what on the deal team
Deal counsel verifies and papers; accountants handle the purchase price allocation and tax treatment after close; corporate development models synergies; an IP consultancy supplies the strength, coverage, and valuation analysis the other three rely on. Sell-side teams use the same work in reverse: a documented portfolio valuation prepared before the process starts is the difference between defending your IP's value and watching a buyer's diligence team define it for you.
Related questions
Buy side or sell side: who should commission the IP valuation?
Both, separately. Buyers need value-to-us analysis no seller will provide. Sellers need a documented valuation before going to market, because in our experience an undocumented IP story gets discounted toward zero under diligence pressure.
What IP findings actually change deal price?
Title and assignment gaps, key patents expiring sooner than the buyer assumed, exclusive licenses already granted, patents that do not cover the flagship product, and unbudgeted maintenance liabilities. Most are fixable or priceable if found early, and deal-threatening if found late.
How early should IP diligence start?
Sell side: months before the process, while there is still time to fix assignment gaps and document value. Buy side: at the letter of intent, since the two-to-six-week window quoted in published estimates compresses fast once the data room opens.
Does the seller's own valuation carry any weight?
Only as far as its assumptions survive interrogation. A valuation with stated methodology and checkable inputs becomes the anchor for negotiation. A number without support becomes a talking point the buyer ignores.
Put the IP number on solid ground
Whichever side of the deal you are on, the IP analysis has to survive the other side's experts. Tell us the timeline and we will scope to it. Discovery calls are free.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.